The Effect of Nintedanib in Post-COVID-19 Lung Fibrosis: An Observational Study

BACKGROUND: Lung fibrosis is a sequela of COVID-19 among patients with severe pneumonia. Idiopathic pulmonary fibrosis and lung fibrosis due to COVID-19 may share many similar features. There are limited data on effects of antifibrotic treatment of infection-related lung fibrosis. This study aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Saiphoklang, Narongkorn, Patanayindee, Pimchanok, Ruchiwit, Pitchayapa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529527/
https://www.ncbi.nlm.nih.gov/pubmed/36199668
http://dx.doi.org/10.1155/2022/9972846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529527/
https://www.ncbi.nlm.nih.gov/pubmed/36199668
http://dx.doi.org/10.1155/2022/9972846

Ejemplares similares